Character and temporal evolution of apoptosis in acetaminophen-induced acute liver failure*.
about
Acetaminophen-Induced Hepatotoxicity: a Comprehensive UpdateTarget biomarker profile for the clinical management of paracetamol overdose.NADPH oxidase 4 regulates homocysteine metabolism and protects against acetaminophen-induced liver damage in miceGlycyrrhizin Protects against Acetaminophen-Induced Acute Liver Injury via Alleviating Tumor Necrosis Factor α-Mediated Apoptosis.Multivariate metabotyping of plasma predicts survival in patients with decompensated cirrhosis.Stratification of paracetamol overdose patients using new toxicity biomarkers: current candidates and future challenges.Acetaminophen hepatotoxicity: an updated review.Keratins: Biomarkers and modulators of apoptotic and necrotic cell death in the liver.Role of TLR4-Mediated PI3K/AKT/GSK-3β Signaling Pathway in Apoptosis of Rat Hepatocytes.Critical differences in toxicity mechanisms in induced pluripotent stem cell-derived hepatocytes, hepatic cell lines and primary hepatocytes.Inhibitory effect of oxymatrine on hepatocyte apoptosis via TLR4/PI3K/Akt/GSK-3β signaling pathway.Natural Dietary Pigments: Potential Mediators against Hepatic Damage Induced by Over-The-Counter Non-Steroidal Anti-Inflammatory and Analgesic Drugs.Acetaminophen hepatotoxicity in mice: Effect of age, frailty and exposure type.
P2860
Q26746501-582B804F-A853-44BB-905B-1E1DE1A031C4Q36072453-268E82C3-0AB9-4912-AE6D-C095EFD061BFQ36422396-805C44D0-161C-4204-BEAF-1834D0D73783Q36852508-2EADB30A-8416-4965-8ADA-91678920E8C7Q36924678-D13B7E87-A05D-4CB2-BF74-A9F6EE593670Q38180741-30F3727A-66DD-4335-899F-D6AAE4019C75Q38299336-4DE9C35E-BA3F-425C-ABDA-01E521F9D20BQ38725581-665E81BD-B902-4350-93C2-E1C86FC76672Q38803358-C1070408-B6DC-4CBF-9FD3-5CB163E70309Q38986528-FA42D227-F742-454A-AE2B-AEFE067CA732Q40162933-408DF08C-A8B4-472B-87D3-2FBE7F5700A2Q48174531-B7FA436F-EAF7-4587-899B-B8871F8C9A1EQ55325779-32A40EB0-AF9A-4773-94B0-ADC305055A20
P2860
Character and temporal evolution of apoptosis in acetaminophen-induced acute liver failure*.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Character and temporal evoluti ...... -induced acute liver failure*.
@en
Character and temporal evoluti ...... -induced acute liver failure*.
@nl
type
label
Character and temporal evoluti ...... -induced acute liver failure*.
@en
Character and temporal evoluti ...... -induced acute liver failure*.
@nl
prefLabel
Character and temporal evoluti ...... -induced acute liver failure*.
@en
Character and temporal evoluti ...... -induced acute liver failure*.
@nl
P2093
P2860
P50
P1476
Character and temporal evoluti ...... n-induced acute liver failure*
@en
P2093
Alberto Quaglia
Anil Dharwan
Charalambos G Antoniades
Elaine M Leslie
Jakirty Rawal
Julia A Wendon
Mark J W McPhail
Nigel D Heaton
R Daniel Abeles
Ragai R Mitry
P2860
P304
P356
10.1097/CCM.0B013E31829791A2
P407
P577
2013-11-01T00:00:00Z